Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,900 | $0.35 | $2,059.10 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 6 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,026,145 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 21, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,400 | $0.37 | $1,998.00 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 5 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,032,045 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 20, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 6,636 | $0.37 | $2,481.86 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 4 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,037,445 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 19, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 4,501 | $0.37 | $1,651.87 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 3 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,044,081 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 18, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 15,300 | $0.35 | $5,293.80 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,048,582 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 17, 2022 Filed Nov 14, 2022 23:37 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 8,098 | $0.34 | $2,712.83 |
DisclosureSEC source: 0001014108-22-000163 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,063,882 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 14, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 3,420 | $0.33 | $1,132.02 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 21 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,071,980 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 13, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 11,314 | $0.33 | $3,733.62 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 20 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,075,400 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 12, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 9,700 | $0.33 | $3,230.10 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 19 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,086,714 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 11, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,988 | $0.33 | $1,988.02 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 18 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,096,414 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 10, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 10,043 | $0.33 | $3,274.02 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 17 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,102,402 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 07, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 24,708 | $0.36 | $8,845.46 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 16 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,112,445 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 06, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 25,098 | $0.44 | $11,143.51 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 15 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,137,153 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 05, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 46,785 | $0.44 | $20,351.48 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 14 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,162,251 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 04, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 19,200 | $0.34 | $6,604.80 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 13 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,209,036 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 03, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 15,022 | $0.33 | $4,957.26 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 12 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,228,236 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 30, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 8,662 | $0.36 | $3,083.67 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 11 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,243,258 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 29, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 3,300 | $0.35 | $1,151.70 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 10 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,251,920 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 28, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 15,649 | $0.33 | $5,211.12 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 9 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,255,220 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 27, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 4,866 | $0.33 | $1,610.65 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 8 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,270,869 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 26, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 17,528 | $0.36 | $6,222.44 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 7 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,275,735 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 23, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,306 | $0.37 | $1,984.44 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 6 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,293,263 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 22, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 17,388 | $0.41 | $7,181.24 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 5 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,298,569 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 21, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,574 | $0.43 | $2,380.10 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 4 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,315,957 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 20, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 10,626 | $0.45 | $4,792.33 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 3 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,321,531 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 19, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 13,870 | $0.49 | $6,726.95 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,332,157 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 16, 2022 Filed Nov 14, 2022 23:17 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 3,200 | $0.51 | $1,641.60 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,346,027 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 15, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 3,900 | $0.53 | $2,070.90 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 26 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,349,227 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 14, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 2,301 | $0.52 | $1,203.42 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 25 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,353,127 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 13, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 2,201 | $0.53 | $1,155.53 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 24 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,335,428 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 12, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 1,700 | $0.54 | $919.70 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 23 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,357,629 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 09, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 13,219 | $0.52 | $6,847.44 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 22 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,359,329 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 08, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 4,592 | $0.52 | $2,397.02 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 21 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,372,548 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 07, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 8,846 | $0.53 | $4,670.69 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 20 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,377,140 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 06, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 6,403 | $0.55 | $3,489.64 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 19 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,385,986 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 02, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 2,001 | $0.55 | $1,092.55 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 18 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,392,389 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 01, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 8,297 | $0.55 | $4,530.16 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 17 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,394,390 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 31, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 4,540 | $0.55 | $2,492.46 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 16 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,402,687 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 30, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 13,487 | $0.57 | $7,633.64 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 15 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,407,227 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 29, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 11,533 | $0.57 | $6,585.34 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 14 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,420,714 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 26, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 60,628 | $0.62 | $37,346.85 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 13 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,432,247 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 25, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 26,945 | $0.72 | $19,346.51 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 12 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,492,875 Read SEC document |
| August 24, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 8,665 | $0.65 | $5,649.58 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 11 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,519,820 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 23, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,900 | $0.64 | $3,764.20 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 10 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,528,485 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 20:04 UTC |
Wolfson MarinaChief Financial Officer
|
GrantCommon Stock Options - Right to Buy · Derivative | 75,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001213900-22-050774 · ownership.xml · derivative · entry 1 Wolfson Marina · CIK 0001797360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 22, 2023, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 20:03 UTC |
Solomon Jonathan EitanDirector · Chief Executive Officer
|
GrantCommon Stock Options - Right to Buy · Derivative | 100,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001213900-22-050773 · ownership.xml · derivative · entry 1 Solomon Jonathan Eitan · CIK 0001792322 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 22, 2023, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 20:01 UTC |
Bassan MeravChief Development Officer
|
GrantCommon Stock Options - Right to Buy · Derivative | 75,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001213900-22-050772 · ownership.xml · derivative · entry 1 Bassan Merav · CIK 0001792702 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-08-22 F1 · derivative.exercise_date: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 22, 2023, and the remainder vesting in 12 equal quarterly installments over three years. Read SEC document |
| August 22, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 5,000 | $0.66 | $3,285.00 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 9 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,534,385 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 19, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 14,600 | $0.64 | $9,329.40 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 8 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,539,385 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 18, 2022 Filed Nov 14, 2022 22:51 UTC |
Ugwumba ChidozieExit Form 4 - former 10% owner
|
SaleCommon Stock | 7,764 | $0.68 | $5,302.81 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 7 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,553,985 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.